C9134 — Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
C9134 is a HCPCS Level II code for factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.. It belongs to the Outpatient Prospective Payment System section. It was terminated on December 31, 2014 and is not valid on new claims.
This code has been terminated
CMS terminated C9134 on December 31, 2014. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for C9134
- Long descriptor
- Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
- Short descriptor
- Factor xiii a-subunit recomb
- Added
- July 1, 2014
- Terminated
- December 31, 2014
- BETOS
- O1E
- Pricing indicator
- 53 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Statute.
Codes adjacent to C9134
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If C9134 is not quite right, the correct code is very often within a few positions of it.
- C9097Inj, faricimab-svoa, 0.1 mgterminated
- C9098Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic doseterminated
- C9101Injection, oliceridine, 0.1 mg
- C9113Injection, pantoprazole sodium, per vialterminated
- C9121Injection, argatroban, per 5 mgterminated
- C9122Mometasone furoate sinus implant, 10 micrograms (sinuva)terminated
- C9132Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activityterminated
- C9133Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.terminated
- C9135Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.terminated
- C9136Injection, factor viii, fc fusion protein, (recombinant), per i.u.terminated
- C9137Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.terminated
- C9138Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.terminated
- C9139Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.terminated
- C9140Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.terminated
- C9141Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.terminated
- C9142Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mgterminated
Questions about C9134
What is HCPCS code C9134?
C9134 is a HCPCS Level II code for factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.. It sits in the Outpatient Prospective Payment System section.
Does Medicare cover C9134?
The CMS HCPCS file marks C9134 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is C9134 still valid?
No. C9134 was terminated on December 31, 2014 and should not be used on new claims.